BioSpace News Archive

84 percent of “attachments” sharing medical information between providers and health plans are exchanged through mail or fax, resulting in administrative inefficiency and delays in patient care

Kala Pharmaceuticals, Inc. announced that it will report first quarter 2019 financial results on Thursday, May 9, 2019.

Recent analyses highlight significant unmet clinical needs and burden of anemia due to chronic kidney disease

Financing to fund quarterly expenses related to the ATHENA first-line maintenance clinical trial in ovarian cancer, beginning in Q2 2019 through study completion

2019 American Psychiatric Association (APA 2019) Annual Meeting, which will be held May 18-22, in San Francisco, Calif.

AVIR Pharma Inc., is pleased to announce that Cresemba™ is now available in Canada.

“Today we finished driving a stake into the ground in our relentless fight against patent trolls – The Federal Circuit Court of Appeals affirmed our award of our legal fees from the Third most litigious patent troll in America – Thermolife International and Ron Kramer” said Jared Wheat, President of Hi-Tech Pharmaceuticals.

Today announced financial results for the first quarter ended March 31, 2019.

Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that it will release its financial results for first quarter 2019 after the close of trading on Thursday, May 9, 2019.

This follows the previous $30 million ASR program Anika announced in May 2018 and completed in July 2018.